Home
About
Overview
Sharing Data
ORCID
Help
History (4)
Delayed adverse reactions to the parenteral administration of iodinated contrast media.
Exposure to multiple sources of polycyclic aromatic hydrocarbons and breast cancer incidence.
Medications for Alcohol Use Disorders in a Primary Care Practice-Based Research Network Implementation Study
p21 (CDKN1A) is a negative regulator of p53 stability.
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
p21 (CDKN1A) is a negative regulator of p53 stability.
p21 (CDKN1A) is a negative regulator of p53 stability. Cell Cycle. 2007 Jun 15; 6(12):1468-71.
View in:
PubMed
subject areas
Cell Cycle
Cell Line, Tumor
Cyclin-Dependent Kinase Inhibitor p21
DNA Damage
Doxorubicin
Gene Expression Regulation
Humans
Immunoblotting
Leupeptins
Proto-Oncogene Proteins c-mdm2
Tumor Suppressor Protein p53
authors with profiles
Igor Roninson